MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Speech and language changes in cognitive impairment subtypes in patients with Parkinson´s disease

    A. Kušnírová, Z. Košutzká, M. Hajdúk, M. Králová, M. Pápayová, M. Egryová, P. Valkovič, Z. Cséfalvay (Bratislava, Slovakia)

    Objective: The aim of our study was to compare speech (intelligibility and comprehensibility) and language (lexical-semantic aspect) abilities with cognitive profiles in patients with Parkinson´s…
  • 2019 International Congress

    Correlation Between PDQ-39 and MDS-UPDRS Scores in a Phase 3 Randomized Controlled Trial of Patients with Parkinson’s Disease

    T. Lokhandwala, A. Lee, B. Yue, A. Thach, B. Navia (Palm Harbor, FL, USA)

    Objective: To describe correlations of the Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) part III scores with the 39-item Parkinson’s disease (PD) questionnaire…
  • 2019 International Congress

    Amylin deposition in the brain of Parkinson’s disease patients

    I. Martinez-Valbuena, R. Valenti-Azcarate, J. Sanchez, I. Marcilla Garcia, G. Marti Andres, MT. Tuñon-Alvarez, MR. Luquin Piudo (Pamplona, Spain)

    Objective: The objective of this study was to determine the presence of amylin deposits in the brain of subjects with synucleinopathies. Background: The link between…
  • 2019 International Congress

    Predictors of Retention for Carbidopa/Levodopa Intestinal Gel in Parkinson Disease

    A. Nagy, T. Davis, T. Hassell, P. Hedera, D. Isaacs, H. Koons, F. Phibbs, S. Afrow, J. Fang (Nashville, TN, USA)

    Objective: To identify predictors of discontinuation of levodopa/carbidopa intestinal gel therapy. Background: Although levodopa/carbidopa intestinal gel (LCIG) is an established treatment for Parkinson's disease complicated…
  • 2019 International Congress

    Parkinson’s Disease Presentation in Calabar, Nigeria

    S. Oparah, U. Williams, J. Mwankon (Calabar, Nigeria)

    Objective: To create a database and describe the presentation of Parkinson's disease patients at the sole tertiary hospital in Calabar, southern Nigeria. Background: Parkinson's disease…
  • 2019 International Congress

    Unraveling biological processes implicated in MSA and PD by transcriptomic analysis

    A. Perez-Soriano, M. Arnal, D. Giraldo, M. Fernandez, T. Botta-Orfila, Y. Compta, R. Fernández-Santiago, M. Ezquerra, D. Tartaglia, MJ. Martí (Barcelona, Spain)

    Objective: To find differential biological processes between synucleinopathies (MSA and PD). Background: Multiple system atrophy (MSA) is an oligodendroglial sinucleinopathy that is often misdiagnosed as…
  • 2019 International Congress

    Braak model in Parkinson disease using MRI biomarkers

    N. Pyatigorskaya, L. Yahia-Cherif, R. Valabregue, R. Gaurav, M. Mongin, C. Ewenczyk, C. Gallea, F. Gargouri, E. Bardinet, I. Arnulf, M. Vidailhet, S. Lehericy (Paris, France)

    Objective: The aim of this study was to test using multimodal MRI biomarkers if the pattern of neurodegeneration in the brain of patients with PD…
  • 2019 International Congress

    A Lewy body disease of widely confirmed Lewy bodies in the cerebral cortexes including the occipital lobe without pathological changes in the hippocampal CA2/3 region

    M. Ryo, K. Hasegawa, I. Saitoh, S. Yagishita (Tokyo, Japan)

    Objective: We present Lewy body disease (LBD) showing unique neuropathological findings which are widely recognized Lewy bodies (LBs) in the cerebral cortexes including the occipital…
  • 2019 International Congress

    BST1 rs4698412 allelic variant increases the risk of gait or balance deficits in patients with Parkinson’s disease

    Y. Shen, J. Wang, K. Zhang (Nanjing, China)

    Objective: We aimed to explore effects of bone marrow stromal cell antigen‐1 (BST1) rs4698412 allelic variant on brain activation and associative clinical symptoms in Parkinson’s…
  • 2019 International Congress

    Exercise and physical activity for people with Progressive Supranuclear Palsy

    S. Slade, D. Finkelstein, J. Mcginley, M. Morris (Ivanhoe, Australia)

    Objective: To (i) evaluate the literature on exercise and physical activity for Progressive Supranuclear Palsy and (ii) make PSP-specific recommendations for exercise programs and trial…
  • « Previous Page
  • 1
  • …
  • 105
  • 106
  • 107
  • 108
  • 109
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley